Illumigyn Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Illumigyn General Information

Description

Developer of a compact imaging colposcope designed to eliminate the subjectivity of cervical cancer exams. The company's colposcope is based on a medical application that delivers down to micron image resolution and has multispectral illumination options to reduce the subjectivity of machine vision technologies, enabling doctors with sophisticated imaging, along with simultaneous complex interventional procedures, to assist in the best clinical outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Communication Center
  • Level 3
  • Neve Ilan 9085000
  • Israel
+972
Primary Industry
Diagnostic Equipment
Corporate Office
  • Communication Center
  • Level 3
  • Neve Ilan 9085000
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Illumigyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jan-2024 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
2. Later Stage VC (Series A) 03-Nov-2021 $33M $40M Completed Generating Revenue
1. Early Stage VC 21-Nov-2016 $7M $7M Completed Generating Revenue
To view Illumigyn’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Illumigyn Patents

Illumigyn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260144430-A1 Speculum camera adaptor Pending 19-Oct-2022
WO-2024084434-A1 Speculum camera adaptor Inactive 19-Oct-2022
AU-2014322687-A1 Optical speculum Active 18-Sep-2013
AU-2014322687-B2 Optical speculum Active 18-Sep-2013
CA-2924274-A1 Optical speculum Active 18-Sep-2013 A61B18/20
To view Illumigyn’s complete patent history, request access »

Illumigyn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Illumigyn Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Ubicom Holdings Holding Company Minority
Yozma Group Korea Venture Capital Minority
To view Illumigyn’s complete investors history, request access »

Illumigyn FAQs

  • When was Illumigyn founded?

    Illumigyn was founded in 2012.

  • Where is Illumigyn headquartered?

    Illumigyn is headquartered in Neve Ilan, Israel.

  • What is the size of Illumigyn?

    Illumigyn has 18 total employees.

  • What industry is Illumigyn in?

    Illumigyn’s primary industry is Diagnostic Equipment.

  • Is Illumigyn a private or public company?

    Illumigyn is a Private company.

  • What is Illumigyn’s current revenue?

    The current revenue for Illumigyn is .

  • How much funding has Illumigyn raised over time?

    Illumigyn has raised $40M.

  • Who are Illumigyn’s investors?

    MedTech Innovator, Ubicom Holdings, and Yozma Group Korea have invested in Illumigyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process